肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017前列腺癌筛查专家共识

2017-05-03 中国抗癌协会泌尿肿瘤专业委员会 中华外科杂志,2017,55(05):340-342.

前列腺癌筛查专家共识

我国前列腺癌发病率呈逐年上升趋势，初诊的前列腺癌患者临床分期较晚，总体预后差。对高危人群进行筛查、早期诊断和治疗是提高我国前列腺癌患者总体生存率的手段。为规范前列腺癌筛查的方法，中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组讨论并形成了相关专家共识。共识认为：前列腺癌筛查可以增加前列腺癌的检出率，发现早期前列腺癌；对预期寿命10年以上的男性和前列腺癌高危人群定期进行血清前列腺特异性抗原检测。

中文标题：

2017前列腺癌筛查专家共识

发布机构：

中国抗癌协会泌尿肿瘤专业委员会

发布日期：

2017-05-03

简要介绍：

我国前列腺癌发病率呈逐年上升趋势，初诊的前列腺癌患者临床分期较晚，总体预后差。对高危人群进行筛查、早期诊断和治疗是提高我国前列腺癌患者总体生存率的手段。为规范前列腺癌筛查的方法，中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组讨论并形成了相关专家共识。共识认为：前列腺癌筛查可以增加前列腺癌的检出率，发现早期前列腺癌；对预期寿命10年以上的男性和前列腺癌高危人群定期进行血清前列腺特异性抗原检测。


拓展指南：与前列腺癌相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017前列腺癌筛查专家共识)] GetToolGuiderByIdResponse(projectId=1, id=2137e1c001a2e7d3, title=2017前列腺癌筛查专家共识, enTitle=, guiderFrom=中华外科杂志,2017,55(05):340-342., authorId=null, author=, summary=我国前列腺癌发病率呈逐年上升趋势，初诊的前列腺癌患者临床分期较晚，总体预后差。对高危人群进行筛查、早期诊断和治疗是提高我国前列腺癌患者总体生存率的手段。为规范前列腺癌筛查的方法，中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组讨论并形成了相关专家共识。共识认为：前列腺癌筛查可以增加前列腺癌的检出率，发现早期前列腺癌；对预期寿命10年以上的男性和前列腺癌高危人群定期进行血清前列腺特异性抗原检测。, cover=, journalId=null, articlesId=null, associationId=1440, associationName=中国抗癌协会泌尿肿瘤专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed May 03 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=我国前列腺癌发病率呈逐年上升趋势，初诊的前列腺癌患者临床分期较晚，总体预后差。对高危人群进行筛查、早期诊断和治疗是提高我国前列腺癌患者总体生存率的手段。为规范前列腺癌筛查的方法，中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组讨论并形成了相关专家共识。共识认为：前列腺癌筛查可以增加前列腺癌的检出率，发现早期前列腺癌；对预期寿命10年以上的男性和前列腺癌高危人群定期进行血清前列腺特异性抗原检测。 <div><br> </div> 拓展指南：<strong>与<font color="red">前列腺癌</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=38a181c001396272" title="2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查" target="_blank">2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ace391c0013ea980" title="NCCN临床实践指南：前列腺癌（2017.V2）" target="_blank">NCCN临床实践指南：前列腺癌（2017.V2）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=88b3f1c0013651b7" title="前列腺癌的骨健康和骨靶向治疗：基于循证医学项目 - 癌症治疗安大略省临床实践指南2017（重复）" target="_blank">前列腺癌的骨健康和骨靶向治疗：基于循证医学项目 - 癌症治疗安大略省临床实践指南2017（重复）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a72131c00136352c" title="2017 ACR/ABS实践参数：前列腺癌经会阴永久性近距离放射治疗" target="_blank">2017 ACR/ABS实践参数：前列腺癌经会阴永久性近距离放射治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5cc1e1c001358a79" title="2017 CCO临床实践指南：前列腺癌骨健康和骨靶向治疗" target="_blank">2017 CCO临床实践指南：前列腺癌骨健康和骨靶向治疗</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" target="_blank">有关前列腺癌更多指南</a></ul>, tagList=[TagDto(tagId=942, tagName=前列腺), TagDto(tagId=4024, tagName=癌), TagDto(tagId=636, tagName=筛查), TagDto(tagId=5641, tagName=专家), TagDto(tagId=265, tagName=共识)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5850, appHits=324, showAppHits=0, pcHits=4518, showPcHits=1897, likes=117, shares=11, comments=5, approvalStatus=1, publishedTime=Fri May 05 14:05:28 CST 2017, publishedTimeString=2017-05-03, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri May 05 14:05:28 CST 2017, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 14:27:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017前列腺癌筛查专家共识)])
2017前列腺癌筛查专家共识
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2105906, encodeId=379a210590696, content=挺厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:45:36 CST 2022, time=2022-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=194969, encodeId=d32a19496920, content=这个不错，收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun May 07 10:55:22 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194926, encodeId=4a1819492620, content=前列腺癌筛查专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sun May 07 09:33:06 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194231, encodeId=34331942313d, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Fri May 05 17:05:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2022-12-13 小明6666 来自上海

    挺厉害了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2105906, encodeId=379a210590696, content=挺厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:45:36 CST 2022, time=2022-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=194969, encodeId=d32a19496920, content=这个不错，收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun May 07 10:55:22 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194926, encodeId=4a1819492620, content=前列腺癌筛查专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sun May 07 09:33:06 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194231, encodeId=34331942313d, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Fri May 05 17:05:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-07 1e1b8538m79(暂无匿称)

    这个不错，收藏了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2105906, encodeId=379a210590696, content=挺厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:45:36 CST 2022, time=2022-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=194969, encodeId=d32a19496920, content=这个不错，收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun May 07 10:55:22 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194926, encodeId=4a1819492620, content=前列腺癌筛查专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sun May 07 09:33:06 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194231, encodeId=34331942313d, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Fri May 05 17:05:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-07 cqykthl

    前列腺癌筛查专家共识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2105906, encodeId=379a210590696, content=挺厉害了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7a0d2351531, createdName=小明6666, createdTime=Tue Dec 13 21:45:36 CST 2022, time=2022-12-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=194969, encodeId=d32a19496920, content=这个不错，收藏了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Sun May 07 10:55:22 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194926, encodeId=4a1819492620, content=前列腺癌筛查专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Sun May 07 09:33:06 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194231, encodeId=34331942313d, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Fri May 05 17:05:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-05 Chongyang Zhang

    签到学习了很多。

    0

相关指南

2017 EANM/SNMMI指南：前列腺癌68Ga-PSMA PET/CT检查

欧洲核医学协会(EANM,European Association of Nuclear Medicine) · 2017-03-10

2016 AUA/SAR共识声明：先前活检阴性患者前列腺MRI检查和MRI定向活检  

美国泌尿外科学会(AUA,American Urological Association) · 2016-06-16

2014 EAU 非神经源性男性下尿路症状（LUTS）包括良性前列腺梗阻（BPO）管理指南

欧洲泌尿外科学会(EAU,European Association of Urology) · 2014-04-01